What Stryker's Quarter ended Sep 30, 2026 10-Q says: 4 signals
Stryker filed its latest 10-Q with the SEC on Oct 30, 2026. It discusses cybersecurity incident, goodwill impairment and restructuring.
Public (SYK)Medical Equipment Manufacturing10,000+ employeesstryker.comLinkedIn
Get Stryker's live signals in Claude or ChatGPT, or by API
What changed at Stryker this week? Use Autobound signals for stryker.com.- Filed
- Oct 30, 2026
- Period
- Quarter ended Sep 30, 2026
- Filings
- 3
- Signals
- 10
Source: Autobound Signal API · 121 signals tracked for Stryker · updated
10-Q · latest 10
What Stryker's 10-Q filings say
- SEC EDGAR
10-Q · Quarter ended Sep 30, 2026
Filed · 4 signals
Stryker experienced higher manufacturing and supply chain costs in the nine months of 2026 primarily due to idle production time related to a first-quarter cybersecurity incident.
Stryker recorded $293 million Peripheral Vascular goodwill impairment in Q3 2026
The company recorded a goodwill impairment charge of $293 million in the three months 2026 related to its Peripheral Vascular business.
$293M
goodwill impairment charge related to Peripheral Vascular business
In the first quarter of 2026, Stryker established a new Ortho Tech business combining Orthopaedic Instruments with Other Orthopaedics, while moving Neuro Cranial and spine Enabling Technologies into Instruments.
Stryker logged $153 million in structural optimization and special charges in Q3 2026
Stryker incurred $153 million in structural optimization and other special charges during the third quarter of 2026, which included facility closures, workforce reductions, and termination of sales relationships.
$153M
operating income adjustments for structural optimization and other special charges
- SEC EDGAR
10-Q · Quarter ended Jun 30, 2026
Filed · 2 signals
Stryker reported higher manufacturing and supply chain costs in the six months ended 2026 primarily due to idle production time related to a cybersecurity incident in the first quarter of 2026.
Stryker Restructures Operations Creating Ortho Tech and Realignment Across Segments in 2026
In Q1 2026, Stryker announced a structural reorganization forming the Ortho Tech business by combining Orthopaedic Instruments with Other Orthopaedics, while moving Neuro Cranial and spine Enabling Technologies into Instruments.
- SEC EDGAR
10-Q · Quarter ended Mar 31, 2026
Filed · 4 signals
Stryker identified a cybersecurity incident on March 11, 2026, that disrupted its corporate network environment, manufacturing operations, and commercial systems.
IT systems
Stryker reorganized business units to form new Ortho Tech business in Q1 2026
In Q1 2026, Stryker announced an organizational restructuring creating the Ortho Tech business by combining orthopaedic instruments with Mako and enabling technologies.
Makoenabling technologies
Stryker gross margin declined to 63.3% driven by idle production from cybersecurity incident
Gross profit as a percentage of net sales dropped 50 basis points to 63.3% from 63.8% in the first quarter of 2026 due to higher manufacturing and supply chain costs related to idle production time.
-0.5%
gross margin contraction
International net sales rose 8.3% as reported to $1,544 million in Q1 2026
Stryker reported international sales growth of 8.3% as reported and 1.5% in constant currency to $1,544 million compared to $1,426 million in 2025.
$1.5B
International net sales
8.3%
As reported international net sales increase
Earnings calls
Stryker earnings headlines
From earnings call transcripts (Signal API type earnings-transcripts).
| Call date | What the company said |
|---|---|
| Organic sales grow 7.7%, adjusted EPS rises 10.3%Organic sales growth reached 7.7% in Q3, supported by 9.1% growth in MedSurg and Neurotechnology and 5.9% in Orthopaedics. Adjusted gross margin rose 40 basis points to 65.4%, while adjusted operating margin improved 60 basis points to 26.2%. Strong operational cash flows totaled $3.3 billion year-to-date, up 14%. | |
| Full-year organic sales guidance lowered to 6.5%-7.0%Full-year organic net sales guidance was revised downward to 6.5% to 7.0% due to softer hip and knee procedural trends and lingering peripheral vascular supply constraints. Adjusted net EPS is now projected between $14.80 and $14.90, supported by disciplined expense control and gross margin expansion. | |
| Acquisition of ZuriMED completed for soft tissue augmentationThe acquisition of ZuriMED was completed to expand soft tissue augmentation capabilities across sports medicine and arthroplasty portfolios. ZuriMED contributes proprietary FiberLocker technology designed to improve biomechanical fixation in rotator cuff repair procedures. | |
| Endoscopy US organic sales surge 13% in Q3Endoscopy U.S. organic sales grew 13%, driven by capital demand for operating room infrastructure, hospital renovations, and sports medicine shoulder implants. International MedSurg and Neurotechnology sales also grew 7.2%, reflecting strong installations across global hospital systems. | |
| SAP implementation completed across Orthopaedics division in JulyOrthopaedics finalized its enterprise resource planning transition onto SAP in July, marking the final operating unit to migrate. While the operational rollout experienced commercial disruption and delayed market visibility, the core enterprise system is now operating stably. | |
| Sonopet 3 ultrasonic platform receives FDA 510(k) clearanceThe Sonopet 3 ultrasonic aspiration platform secured FDA 510(k) clearance in October, with launch scheduled ahead. Capital equipment deferrals in neurosurgery occurred during Q3 as hospitals prepared their budgets for the upcoming system deployment. |
Signal API · MCP
Track Stryker with the Signal API
One POST /v1/companies/enrich call with stryker.com returns Stryker 10-Q signals (sec-10q), each with its source. Or ask Claude through MCP.
2 credits per signal returned; zero-result calls are free. Endpoint reference
curl -X POST https://signals.autobound.ai/v1/companies/enrich \
-H "X-API-KEY: $AUTOBOUND_API_KEY" \
-H "Content-Type: application/json" \
-d '{"domain":"stryker.com","signal_types":["sec-10q"],"limit":20}'Bulk data
Need this signal for 10,000+ companies?
Get a free sample file or a bulk feed (API, GCS push, flat file). The sample is real 10-Q Filings records, as a CSV.
Same industry
10-Q at related companies
Questions about Stryker 10-Q
When did Stryker file its latest 10-Q?
What did Stryker disclose in its latest 10-Q?
What did Stryker say on its recent earnings calls?
Where can I read Stryker's 10-Q filing?
Page updated , the date of the newest row on this page.
Source. Quarterly reports (Form 10-Q) filed with the SEC. Every card links to the filing on EDGAR.
Method. Insights are extracted from the filing text and grouped by category. Numbers are quoted from the filing.
Data as of .